Praful Chakkarwar – Country Manager, Novo Nordisk Pharma Singapore
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Novo Nordisk is a global healthcare company headquartered in Denmark. They are committed to driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk has more than 90 years of innovation and leadership in diabetes care. They also focus on other serious chronic conditions: haemophilia, growth disorders and obesity.
Novo Nordisk employs approximately 43,200 people in 79 countries and markets its products in more than 170 countries.
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
Cecilia Radu of Novo Nordisk Romania shares her tumultuous four years that have seen declining market share and…
Calin Galaseanu, recently appointed general manager of Novo Nordisk Hungary, elaborates on the country’s strong…
Steve Profit, general manager of Novo Nordisk Taiwan, shares a newcomers’ perspective as a recent transplant to…
John Dawber, vice president and general manager of Novo Nordisk Thailand, offers his first impressions of the Thai…
Niels Abel Bonde, general manager of Novo Nordisk Sweden, explains the strategic significance of the Swedish market…
Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved…
Rana Azfar, vice-president & general manager of Novo Nordisk Korea offers his impressions of the Korean market…
Olga Insua, the new American general manager for Novo Nordisk Portugal, fresh off the plane from Spain, provides an…
Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant…
Marijus Valatka, general manager Lithuania, Latvia and Estonia at Novo Nordisk, explains the current challenges and…
Allan Finkel, recently voted Novo Nordisk’s best GM globally, speaks about the partnerships and projects that the…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three…
Brian Hilberdink, President of Novo Nordisk Canada, highlights the key role that Canada plays as a pilot market for…
Mogens Guldberg, general manager of Novo Nordisk Austria, the Danish global powerhouse focused on innovative…
Alexander Boiko, general manager of Novo Nordisk Ukraine, provides insights into the recent progress and remaining…
Diabetes is well managed in Switzerland’s patient-centric healthcare system, yet with new data showing Novo…
Peter Ulvskjold, the Corporate Vice President of International Operations in Southeast Asia, highlights the…
A native of Serbia, Aleksandar Ciric provides his first impressions of the Slovak market and business atmosphere,…
In Mexico, more than 13 million people live with diabetes, while 71 percent of the total population have obesity or…
In part two of an exclusive interview, Novo Nordisk’s Maziar Mike Doustdar expands on the potential of emerging…
In part one of an exclusive interview (part two here), Novo Nordisk’s Maziar Mike Doustdar explains the…
Novo Nordisk Hungary GM Zsolt Jozsa highlights the growing prevalence of diabetes in Hungary, the gap in treatment…
Dr. Costas Piliounis discusses the importance of containing diabetes, the dampening effects budget ceilings have on…
In Egypt’s diverse marketplace, Novo Nordisk is bringing care to patients across the country with a range of…
In a market under strong pressures to contain costs, launching innovative products in a crowded market can be a…
Novo Nordisk Turkey has taken a degree of leadership by working to facilitate and encourage cooperation and…
Novo Nordisk’s market access and public affairs director discusses the state of diabetes management in Mexico,…
The corporate vice president for the Africa region of the multinational at the forefront of the fight against…
The new country manager of the multinational at the forefront of the fight against diabetes in Algeria sheds…
The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian…
Novo Nordisk Malaysia’s general manager shares the ongoing fight to cure diabetes and talks about the necessity…
PharmaBoardroom first interviewed Erik Lommerde as general manager of Novo Nordisk Netherlands four years ago. In…
In a world where diabetes increasingly more common, Poland has not been spared, with 2.5 million diabetic patients…
Christine Marie D. Rosal, Country Manager of Novo Nordisk Pharmaceuticals (Philippines) gives a startling image of…
Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market…
Novo Nordisk CEO Lars Rebien Sørensen discusses the company’s commitment to curing diabetes, his own…
As Novo Nordisk is celebrating its 90 year anniversary this year, may you please begin this interview by discussing…
Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities…
Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly…
Looking into your background, we see that you have developed your career in the local industry’s top 3…
Would you like to provide our international readers with a brief introduction into Novo Nordisk’s Turkish…
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our…
Diabetes affects an estimated 6 million Brazilians, a figure which is expected to double by 2025, in line with many…
Novo Nordisk is one of the very few pharmaceutical multinationals that has such a strong focus on one therapeutic…
Coincidentally, our meeting today comes two days after World Diabetes Day. How was this day commemorated in the…
Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in…
Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in…
Novo Nordisk just celebrated 50 years in France; what have been some of the more recent events that have marked the…
Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that…
Novo Nordisk is one of the very few pharmaceutical multinationals that have a strong focus on one therapeutic area.…
We found a Capital Markets Day presentation from Novo Nordisk that talked about the “rule of halves”…
Novo Nordisk’s largest insulin production facility outside of Denmark is in Latin America, in Brazil. Can you…
We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not…
Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the…
Novo Nordisk announced last year the development of an insulin plant in the Kaluga region not far from Moscow. What…
Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was…
This year’s Q1 results for Novo Nordisk were extremely positive with a 23% increase in profit. While this growth…
Given that Asia is leading growth in the global pharmaceutical market, how is Novo Nordisk represented in the…
Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could…
Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in…
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…
Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…
The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
Sweden’s USD 4.8 billion pharmaceutical market, its population size of 10 million and marginal positioning on the…
Cecilia Radu of Novo Nordisk Romania shares her tumultuous four years that have seen declining market share and…
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and…
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Calin Galaseanu, recently appointed general manager of Novo Nordisk Hungary, elaborates on the country’s strong…